IIT Madras and IRFC Launch India’s First Single-Cell Omics Translational Research Lab
On November 17, 2025, the Indian Institute of Technology Madras (IIT Madras) inaugurated the nation’s first Single Cell Omics Translational (SCOT) Research Laboratory. This groundbreaking initiative is a collaboration with the Indian Railways Finance Corporation (IRFC), a Navratna Public Sector Enterprise, and represents a significant advancement in India’s precision healthcare ecosystem.
About the SCOT Lab
The SCOT Lab is designed to bridge the gap between engineering and medicine, focusing on enhancing public health through innovative research. With a generous Corporate Social Responsibility (CSR) grant of ₹10.83 crore from IRFC, the lab is situated within the Department of Medical Sciences and Technology (DMST) at IIT Madras.
Equipped with state-of-the-art instrumentation, the SCOT Lab aims to facilitate:
- Early diagnosis of diseases
- Disease prognosis
- Biomarker discovery
- Drug screening across a range of diseases, including cancer, cardiovascular diseases, infectious diseases, inflammatory conditions, metabolic disorders, and other non-communicable diseases.
Inauguration Ceremony
The launch ceremony was attended by several dignitaries, including:
- Prof. V Kamakoti, Director, IIT Madras
- Ms. Usha Venugopal, Member (Finance), Ministry of Railways
- Mr. Manoj Kumar Dubey, Chairman and Managing Director, IRFC
- Prof. Ashwin Mahalingam, Dean (Alumni and Corporate Relations), IIT Madras
- Prof. Boby George, Head, DMST, IIT Madras
- Prof. Krishna Kumar, DMST, IIT Madras
- Prof. Anubama Rajan, Project Coordinator, DMST
These leaders expressed their enthusiasm for the potential impact of the SCOT Lab on medical research and healthcare outcomes in India.
Vision for Improved Health Outcomes
During the inauguration, Ms. Usha Venugopal highlighted the importance of the SCOT Lab in enhancing medical research capabilities. She stated, “The inauguration of the SCOT Research Lab is a welcome step toward building stronger capabilities in medical research. The support extended through IRFC’s CSR funding will aid studies that have the potential to improve early diagnosis and develop better therapies. This collaboration shows how institutions can work together for larger national goals.”
Ms. Venugopal expressed her hope that the facility would contribute to knowledge, innovation, and improved health outcomes in the future.
Expected Outcomes from the SCOT Lab
The SCOT Lab is expected to yield several significant outcomes, including:
- Identification of novel biomarkers for early disease detection and treatment response.
- Development of personalized therapeutic strategies through single-cell profiling.
- Advancement of early detection and drug/vaccine discovery platforms.
- Strengthening of India’s precision medicine ecosystem by integrating molecular data with clinical insights.
Additionally, the lab will serve as a national training hub for clinicians, scientists, and engineers, fostering the next generation of experts in:
- Single-cell transcriptomics
- Functional genomics
- Translational medicine
It will also provide training for medical and engineering students in advanced cell-based analytics and computational biology, ensuring a well-rounded educational experience.
Conclusion
The establishment of the SCOT Lab at IIT Madras marks a pivotal moment in India’s healthcare landscape. By integrating cutting-edge technology with medical research, this facility is poised to make significant contributions to early disease detection, personalized medicine, and overall health outcomes in the country.
Note: The information presented in this article is based on the latest updates available as of November 2025.
